Comparing Neural Correlates of Consciousness: From Psychedelics to Hypnosis and Meditation
Flora Moujaes, Nathalie M. Rieser, Christophe Phillips, Nuno M.p. de Matos, Mike Brügger, P. Dürler, Lukasz Smigielski, Philipp Stämpfli, Erich Seifritz, Franz X. Vollenweider, Alan Anticevic, Katrin H. Preller
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging July 17, 2023 DOI: 10.1016/j.bpsc.2023.07.003 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Observational cohort Peer reviewed |
|---|---|
| Sample size | 107 |
| Population | Healthy adults |
| Interventions | Psilocybin LSD Hypnosis Meditation |
| Dose | psilocybin 0.2 mg/kg orally, LSD 100 μg orally |
| Topics | Default mode network Meditation Psilocybin |
| Keywords | Hypnosis Psychological intervention Consciousness Clinical psychology Hallucinogen Cognition Alternative medicine |
| Citations | 19 |
| Key findings | No single brain network was altered across all four methods of inducing altered states, and pharmacological and nonpharmacological interventions showed distinct, individually predictive connectivity patterns. |
Abstract
Background: Pharmacological and nonpharmacological methods of inducing altered states of consciousness (ASCs) are becoming increasingly relevant in the treatment of psychiatric disorders. While comparisons between them are often drawn, to date no study has directly compared their neural correlates.
Methods: To address this knowledge gap, we directly compared 2 pharmacological methods (psilocybin 0.2 mg/kg orally [n = 23] and lysergic acid diethylamide [LSD] 100 μg orally [n = 25]) and 2 nonpharmacological methods (hypnosis [n = 30] and meditation [n = 29]) using resting-state functional connectivity magnetic resonance imaging and assessed the predictive value of the data using a machine learning approach.
Results: We found that 1) no network reached significance in all 4 ASC methods; 2) pharmacological and nonpharmacological interventions of inducing ASCs showed distinct connectivity patterns that were predictive at the individual level; 3) hypnosis and meditation showed differences in functional connectivity when compared directly and also drove distinct differences when jointly compared with the pharmacological ASC interventions; and 4) psilocybin and LSD showed no differences in functional connectivity when directly compared with each other, but they did show distinct behavioral-neural relationships.
Conclusions: Overall, these results extend our understanding of the mechanisms of action of ASCs and highlight the importance of exploring how these effects can be leveraged in the treatment of psychiatric disorders.
Comparable studies
Other observational and cohort studies on psilocybin and meditation, most cited first.
Citations in the library
Cited by 13
- Psychedelics and disorders of consciousness: the current landscape and the path forward. Neuroscience of Consciousness June 15, 2024
- Classification schemes of altered states of consciousness. Neuroscience & Biobehavioral Reviews August 1, 2025
- Neurocognitive effects of psilocybin: A systematic and comprehensive review of neuroimaging studies in humans. Neuroscience & Biobehavioral Reviews August 1, 2025
- Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trial PLoS Medicine September 19, 2025
- Multimodal Neuroimaging of the Effect of Serotonergic Psychedelics on the Brain. AJNR. American journal of neuroradiology February 15, 2024
and 8 more in the library
Cites 38
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- Meditation experience is associated with differences in default mode network activity and connectivity Proceedings of the National Academy of Sciences November 23, 2011
- Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology July 1, 2008
- Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases The Journal of Nervous and Mental Disease March 4, 2014
and 33 more in the library